HLB Pharmaceutical's chart data is dated 2026-10-08. There is no active technical signal. There are 0 published signal records.
HLB Pharmaceutical last closed at ₩13,030 (+3.66%) on 2026-10-08. Listed on KOSDAQ. Trailing 12 months PER is 169.5×. Its overall grade ranks 105 of 308 stocks in Healthcare.
About this company
HLB Pharmaceutical last closed at ₩13,030 (+3.66%) on 2026-10-08. Listed on KOSDAQ.
Details →Reported results
Position in sector
Healthcare · Overall B+ · 105/308
Valuation grade B-
Recent filings
DART · received recent list, not a complete filing history. Factual information, not investment advice.
Related stocks
- HLBRelated theme
HLB그룹 핵심 계열사로 신약개발·라이선스아웃 및 그룹 시너지와 직접 연결
- HLB생명과학Related theme
HLB그룹 내 바이오/의약 사업 축을 공유하는 계열사
- HLB테라퓨틱스Related theme
HLB그룹 내 신약개발 파이프라인과 사업적 연관성이 큼
About HLB Pharmaceutical
- What technical signals does HLB Pharmaceutical (047920) have?
- HLB Pharmaceutical current technical signals: no active technical signal.
- Is HLB Pharmaceutical a cup-and-handle pattern?
- No. HLB Pharmaceutical has no valid Cup signal right now.
- What published figures are available for HLB Pharmaceutical?
- Market cap: KRW 463.81B. Trailing 12 months PER: 169.5×. Latest quarter PBR: 3.57×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Turn what you saw on this name into a strategy
Ask Q about HLB Pharmaceutical, or open the plan table on the main site.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.